Peer Review reports
From: In vivo antiangiogenic effect of nimbolide, trans-chalcone and piperine for use against glioblastoma
Original Submission | ||
---|---|---|
26 Jun 2023 | Submitted | Original manuscript |
10 Aug 2023 | Author responded | Author comments - Alok Chandra Bharti |
Resubmission - Version 2 | ||
10 Aug 2023 | Submitted | Manuscript version 2 |
Resubmission - Version 3 | ||
Submitted | Manuscript version 3 | |
24 Aug 2023 | Reviewed | Reviewer Report - Sabine Matou-Nasri |
4 Sep 2023 | Reviewed | Reviewer Report |
21 Sep 2023 | Author responded | Author comments - Alok Chandra Bharti |
Resubmission - Version 4 | ||
21 Sep 2023 | Submitted | Manuscript version 4 |
5 Oct 2023 | Author responded | Author comments - Alok Chandra Bharti |
Resubmission - Version 5 | ||
5 Oct 2023 | Submitted | Manuscript version 5 |
17 Oct 2023 | Reviewed | Reviewer Report |
19 Oct 2023 | Reviewed | Reviewer Report - Sabine Matou-Nasri |
8 Nov 2023 | Author responded | Author comments - Alok Chandra Bharti |
Resubmission - Version 6 | ||
8 Nov 2023 | Submitted | Manuscript version 6 |
Publishing | ||
9 Nov 2023 | Editorially accepted | |
30 Nov 2023 | Article published | 10.1186/s12885-023-11625-4 |
You can find further information about peer review here.